SARS-CoV-2 — Precision Vaccinations

Fact checked by Robert Carlson, MD

May 30

3 min read

SARS-CoV-2 Vaccine Candidate Doses Phase 2 Study Participants

Moderna vaccine mRNA-1273 launches phase 2 clinical trial

virus and person with mask on

Fact checked by Robert Carlson, MD

May 29

4 min read

Late-Stage Study Combines an Antiviral with Immune Modulator For Treating COVID-19 Patients

Actemra, RoActemra, and Remdesivir treatment study launched

hospital researchers in a lab

Fact checked by Robert Carlson, MD

May 28

3 min read

1 Billion Vaccine Adjuvant Doses Promised

GSK adjuvant technology could enhance various SARS-CoV-2 coronavirus vaccines

woman training with ropes to get stronger

Fact checked by Robert Carlson, MD

May 26

3 min read

Merck Teams To Tackle SARS-CoV-2 Vaccine

Merck recombinant vesicular stomatitis virus (rVSV) technology is the basis for SARS-CoV-2 prevention vaccine

stop watch and a microscope

Fact checked by Robert Carlson, MD

May 25

4 min read

Coronavirus Vaccine Launches Study in Australia and the USA

Novavax identified NVX‑CoV2373 as its lead SARS-CoV-2 vaccine candidate following pre-clinical testing

depiction of coronavirus